Sulfite reductase [NADPH] flavoprotein alpha-component

BE0002963ProteinEscherichia coli (strain K12)cysJ

Component of the sulfite reductase complex that catalyzes the 6-electron reduction of sulfite to sulfide. It is acted on by 2 drugs in DrugBank.

Gene name: cysJ
UniProtKB entry: P38038Swiss-Prot
Residues / weight: 599 residues · 66,269 Da
Also known as: 1.8.1.2 · SiR-FP

Resolves to

Protein

UniProtP38038UniProt nameCYSJ_ECOLI

Gene

NCBI Gene947239

Pharmacology

KEGGecj:JW2734

Structure

PDB1DDGPDB1DDIPDB1YKG

Drugs

What you can answer from here — as of September 07, 2019

2DrugsApproved to experimental, with action, bond type and pharmacological action

11GO termsFunction, process and component, as structured annotations

3Pfam domainsDomain architecture mapped to Pfam families and clans

14+ReferencesStructured and connected to the statements they support

Which approved drugs act on Sulfite reductase [NADPH] flavoprotein alpha-component, how selective are they, and which programs against it are still in active trials?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account